BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16820145)

  • 1. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    Clin Chim Acta; 2006 Nov; 373(1-2):127-31. PubMed ID: 16820145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    Clin Chim Acta; 2006 Mar; 365(1-2):230-5. PubMed ID: 16199026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of pulse pressure with carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    Blood Press; 2007; 16(1):56-62. PubMed ID: 17453753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.
    Wakabayashi I; Masuda H
    Thromb Res; 2007; 121(1):95-102. PubMed ID: 17439823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus.
    Fukui M; Ose H; Kitagawa Y; Yamazaki M; Hasegawa G; Yoshikawa T; Nakamura N
    Metabolism; 2007 Sep; 56(9):1167-73. PubMed ID: 17697857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of aortic stiffness on cardiovascular disease in patients with chest pain: assessment with direct intra-arterial measurement.
    Choi CU; Park EB; Suh SY; Kim JW; Kim EJ; Rha SW; Seo HS; Oh DJ; Park CG
    Am J Hypertens; 2007 Nov; 20(11):1163-9. PubMed ID: 17954362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease.
    Maca T; Mlekusch W; Doweik L; Budinsky AC; Bischof M; Minar E; Schillinger M
    Eur J Clin Invest; 2007 Mar; 37(3):180-6. PubMed ID: 17359485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
    Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes.
    Smith A; Karalliedde J; De Angelis L; Goldsmith D; Viberti G
    J Am Soc Nephrol; 2005 Apr; 16(4):1069-75. PubMed ID: 15743996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and renal failure: effects on large artery stiffness.
    Aoun S; Blacher J; Safar ME; Mourad JJ
    J Hum Hypertens; 2001 Oct; 15(10):693-700. PubMed ID: 11607799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of arterial stiffness in women with gestational diabetes.
    Bulzico DA; Zajdenverg L; Cabizuca CA; de Oliveira JE; Salles GF
    Diabet Med; 2012 Feb; 29(2):227-31. PubMed ID: 22235986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness.
    Tedesco MA; Natale F; Di Salvo G; Caputo S; Capasso M; Calabró R
    J Hum Hypertens; 2004 Jul; 18(7):469-73. PubMed ID: 14985776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.
    Mattace-Raso FU; van der Cammen TJ; Hofman A; van Popele NM; Bos ML; Schalekamp MA; Asmar R; Reneman RS; Hoeks AP; Breteler MM; Witteman JC
    Circulation; 2006 Feb; 113(5):657-63. PubMed ID: 16461838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I; Cetinarslan B; Cantürk Z
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
    Habib SS; Aslam M
    Saudi Med J; 2003 Jun; 24(6):647-51. PubMed ID: 12847596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between homocysteine levels and atherosclerosis in Japanese type 2 diabetic patients.
    Anan F; Masaki T; Umeno Y; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
    Metabolism; 2007 Oct; 56(10):1390-5. PubMed ID: 17884450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
    Jae SY; Heffernan KS; Lee MK; Fernhall B; Park WH
    Am J Cardiol; 2008 Sep; 102(6):700-3. PubMed ID: 18773991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and other risk factors for cerebral infarction.
    Konemori G
    Hiroshima J Med Sci; 1995 Sep; 44(3):65-77. PubMed ID: 8567315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.